Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

184 results about "Oxyde nitrique" patented technology

Hydrogen sulfide / nitric oxide synergistic anti-inflammatory and anti-coagulation repair promoting coating as well as preparation method and application thereof

The invention relates to the field of biomedical materials, discloses a hydrogen sulfide / nitric oxide synergistic anti-inflammatory and anti-coagulation repair promoting coating as well as a preparation method and application thereof, and provides a coating with anti-inflammatory, anti-coagulation and tissue repair promoting functions through the synergistic effect of hydrogen sulfide and nitric oxide. The coating comprises a hydrogen sulfide donor which can spontaneously release hydrogen sulfide or a precursor thereof or release hydrogen sulfide under external stimulation; the coating further comprises a component capable of catalyzing the release of nitric oxide from the endogenous nitric oxide donor. The coating is covalently connected with the surface of a base material through a chemical means to form firm interface bonding; and the coating has a multi-cross-linked network structure, so that the coating is endowed with good stability, and long-term functional application of the coating on the surface of a biomedical material is ensured. The method can be widely applied to surface modification of biomedical materials, especially coating functionalization of implanted instruments such as valve clips, intravascular stents, heart valves, occluders, vascular grafts and myocardial patches.
Owner:SICHUAN UNIV

Low-intensity focused ultrasound response nanoparticles for enhancing thrombus targeting and penetration, preparation method of low-intensity focused ultrasound response nanoparticles and application of low-intensity focused ultrasound response nanoparticles in anti-thrombus treatment

PendingCN119235822Ahigh bleeding riskeffective thrombus therapyPharmaceutical non-active ingredientsBlood disorderFocus ultrasoundUltrasonic cavitation
The invention relates to the technical field of nano-drugs, in particular to low-intensity focused ultrasound response nanoparticles for enhancing thrombus targeting and penetration, a preparation method of the nanoparticles and application of the nanoparticles in anti-thrombus treatment. The low-intensity focused ultrasound response nanoparticle for enhancing thrombus targeting and penetration comprises a platelet membrane shell, and a core is formed by wrapping perfluoropentane and L-arginine with polylactic acid-glycolic acid copolymer-polyethylene glycol. The platelet membrane ensures that the nanoparticles specifically target a thrombus part; under the stimulation of LIFU, the nanobubbles penetrate through the deep layer of thrombus, L-arginine is oxidized into L-citrulline, and nitric oxide is formed. Meanwhile, the LIFU triggers liquid-gas phase change and nitric oxide release, the ultrasonic cavitation effect is enhanced through the synergistic effect, thrombus structures including red blood cells, blood platelets and fibrin are specifically attacked, and efficient thrombolysis treatment is achieved. According to the technical scheme, the technical problem that the thrombolysis effect of ultrasonic nanoparticles is not ideal can be solved, and good clinical application prospects are achieved.
Owner:THE SECOND AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIV

Ultrasonic activation type piezoelectric gel dressing as well as preparation method and application thereof

The invention discloses an ultrasonic activation type piezoelectric gel dressing and a preparation method and application thereof.The surface of a system is an antibacterial hydrogel layer, the antibacterial hydrogel layer is composed of polyethyleneimine (PEI) and polyvinyl alcohol (PVA) cross-linked hydrogel, and ultrasound and current can be transmitted to a deep area; bT-dNO piezoelectric nanoparticles are packaged inside, and BT-dNO is prepared by coating a nitric oxide (NO) donor on the surface of piezoelectric barium titanate (BT) subjected to hydroxylation and dopamine modification. Under the stimulation of low intensity focused ultrasound (LIFU), the donor can release NO as required, and the BT nanoparticles can generate reactive oxygen species (ROS) and output piezoelectric current. The dressing system has an effective combined repair effect, excellent biocompatibility and good anti-inflammatory ability.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Application of squalene and pharmaceutical composition thereof in preparation of medicine for preventing or treating endotoxemia

The invention discloses an application of squalene or a pharmaceutically acceptable salt thereof in preparation of a medicine for preventing or treating endotoxemia. Experiments show that squalene significantly relieves LPS-induced endotoxemia liver injury through a multi-target mechanism, squalene not only relieves inflammatory response by inhibiting release of inflammatory factors, but also relieves oxidative stress by activating an antioxidant pathway, and the squalene has dual action mechanisms. The invention further provides application of the squalene-containing composition to preparation of the medicine for treating endotoxemia, squalene and glucocorticoid show a synergistic effect in the aspect of inhibiting TNF-alpha, AST can be reduced more remarkably by combining squalene and glucocorticoid, and the effect of dual inhibition of inflammatory mediators is achieved. Besides, the composition of the inducible nitric oxide synthase and squalene is applied to the preparation of the medicine for treating endotoxemia, and the inducible nitric oxide synthase inhibitor can inhibit the activity of iNOS, so that the excessive generation of nitric oxide is reduced, and the inflammatory reaction is further inhibited synergistically.
Owner:INST OF BIOLOGICAL & MEDICAL ENG GUANGDONG ACAD OF SCI

Silicone rubber plate for blending bone cement and preparation process of silicone rubber plate

The invention discloses a silicone rubber plate for blending bone cement and a preparation process thereof, and relates to the technical field of silicone rubber plates, the preparation process comprises the following steps: adding silicone rubber, fluorinated silicone rubber and a double vulcanizing agent into a kneading machine, adjusting roller spacing, preparing into tablets, and vulcanizing to obtain a silicone rubber raw sheet; cutting and forming a silicone rubber raw sheet, and ultrasonically cleaning in ethanol for later use; the preparation method comprises the following steps: treating the surface of a cleaned raw silicon rubber sheet by using a nanosecond laser and performing laser drilling treatment by using a picosecond laser in sequence, then preparing nano silicon dioxide through hydrolytic condensation of ethyl silicate to fill holes, cleaning a drilling area on the surface by using the picosecond laser, and finally performing hydrophobic modification by using hexamethyldisilazane to obtain the super-hydrophobic silicon rubber plate. The preparation method comprises the following steps: carrying out sulfydryl modification on the surface of a super-hydrophobic silicone rubber plate, grafting ammonium bromide on the surface of the super-hydrophobic silicone rubber plate through an ultraviolet sulfydryl olefin reaction, grafting through an L-proline reaction, and finally absorbing nitric oxide to be saturated to obtain the silicone rubber plate for blending the bone cement.
Owner:SHANGHAI REBONE BIOMATERIALS

Processes for preparing nitrosylated propanediols, compositions comprising the same, and medical uses thereof

Disclosed is a process for the synthesis of mono- and bis-nitrosylated propanediols, as well as compositions and pharmaceutical formulations that includes the compounds. The process proceeds by reacting a corresponding propanediol that is not nitrosylated with a source of nitrite, optionally in the presence of a suitable acid. When the source of nitrite is an organic nitrite, reacting step is performed in a suitable organic solvent, and when the source of nitrite is an inorganic nitrite, the reacting step is performed in a bi-phasic solvent mixture comprising an aqueous phase and a non-aqueous phase. Also disclosed are methods of treating a condition wherein administration of nitric oxide (NO) has a beneficial effect by administering said compounds, compositions or formulations.
Owner:ATTGENO AB

Nitric oxide gel for treating endometrial injury

The nitric oxide gel for treating endometrial injury is composed of a gel matrix and a nitric oxide gas solution, the nitric oxide gas solution is uniformly dispersed in the gel matrix, and the volume ratio of the gel matrix to the nitric oxide gas solution is 3: 1-1: 3. The gel matrix is composed of one or more of poloxamer and derivatives thereof, povidone, carbomer and cellulose derivatives, and the nitric oxide gas solution is formed by dispersing nitric oxide gas in absolute ethyl alcohol or water-free and oxygen-free polyhydric alcohol which is in a liquid state at the temperature of 25 DEG C. According to the nitric oxide gel for treating the endometrial injury, the limitation bottleneck of the nitric oxide gel for treating the endometrial injury is overcome, meanwhile, the safe, effective, convenient and economical requirements of clinical treatment are met, and the effect of nitric oxide on treating the endometrial injury is fully exerted.
Owner:WENZHOU MEDICAL UNIV

Pyrimidine sGC stimulators

The present disclosure relates to stimulators of soluble guanylate cyclase (sGC), pharmaceutically acceptable salts thereof and pharmaceutical formulations comprising them and their use, alone or in combination with one or more additional agents, for the treatment of various diseases wherein the concentration of nitric oxide (NO) and / or the concentration of cyclic guanosine monophosphate (cGMP), or both, is increased, such as, for example, the concentration of nitric oxide (NO) and / or the concentration of cyclic guanosine monophosphate (cGMP). Or regulation of the NO pathway is desirable. In some embodiments, the compound is a compound of Formula I or a pharmaceutically acceptable salt thereof. # imgabs0 #
Owner:TISENTO THERAPEUTICS INC

A hybrid of 2-(2-phenylethyl) chromone and lignan and its application

ActiveCN118994185BOrganic active ingredientsOrganic chemistryLignan formationAgarwood
The present invention belongs to the field of agarwood, and in particular to a kind of 2-(2-phenylethyl) chromone and lignan heterocompound and its application. The present invention uses the agarwood produced by thick-leaved agarwood tree as raw material, and after reflux extraction, successively adopts silica gel, Sephadex LH-20 gel, high performance liquid chromatography and other chromatographic techniques to separate and purify to obtain 1 monomer compound, and its structure is identified by spectral methods such as mass spectrometry and nuclear magnetic resonance and combined with physicochemical properties. It is retrieved as a new compound by SciFinder and named as thick-leaved agarwood alcohol (aquicrassnol), which is the first heterocompound formed by 2-(2-phenylethyl) chromone and lignan found in agarwood. It has been verified by experiment that the compound has an inhibitory effect on the production of nitric oxide in mouse mononuclear macrophage RAW264.7 induced by lipopolysaccharide, and its half-maximal inhibitory concentration value is 47.53±2.14μmol / L, which has anti-inflammatory activity.
Owner:INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI

Amphiphilic polyurethane capable of realizing post-crosslinking and controllable release of nitric oxide as well as preparation method and application of amphiphilic polyurethane

The invention discloses amphiphilic polyurethane capable of realizing post-crosslinking and controllable release of nitric oxide as well as a preparation method and application of the amphiphilic polyurethane, and belongs to the technical field of materials for glucose detection. A main chain of the polyurethane is composed of a hydrophobic chain segment, a hydrophilic chain segment, a polydimethylsiloxane chain segment and a-O-(CH2) n-Se-Se-(CH2) n-O-group, wherein n is equal to 1 to 5; a side chain containing an epoxy group is also arranged on the main chain. According to the polyurethane material, on the basis that a main chain contains a double-selenium chain segment, a side chain containing an epoxy group is introduced into the main chain, so that the polyurethane material has a post-crosslinking function, a polyurethane glucose limiting film can be prepared by adding a crosslinking agent in the later period, the mechanical strength and hardness of the polyurethane glucose limiting film can be improved, and the degradation rate of a double-selenium structure is reduced; and the shelf life of the CGM product is prolonged.
Owner:JIANGSU YUWELL POCT BIOLOGICAL TECH CO LTD +2

Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system

A composition and method of providing nitric oxide and nitrite therapy to patients whereby a therapeutic amount is bioavailable within approximately 30 minutes of administration. In embodiments of the invention, nitric oxide is produced in the oral cavity.
Owner:HUMAN POWER OF N CO +1

Carotid artery dilation device

ActiveCN224307687UDoes not change electrical parametersMagnetotherapy using coils/electromagnetsDrug treatmentBiology
This utility model relates to an innovation of a carotid artery vasodilator that can be used at home and in the emergency room as a supplement to drug treatment for conditions such as carotid artery obstruction in the neck region. It increases the production of nitric oxide mediated by endothelial nitric oxide synthase in the intact endothelial layer of the carotid artery, which is located on the inner surface of the neck brace. It can be applied for a certain period of time for each patient. The intermittent or continuous operation function can be selected through an adjustable power circuit. It only affects the lesion area and does not affect the patient's peripheral blood vessels. It can be used in situations where nitrates may be prohibited. It prevents the reduction of blood flow to the brain tissue that may occur due to jugular venous constriction. The flexible structure of the applicator neck brace (9) can be maintained in the application area for a long time and includes a pulsed magnetic field (PMF).
Owner:SÜLEYMAN DEMİREL ÜNİVERSİTESİ İDARİ VE MALİ İŞLER DAİRE BAŞKANLIĞI GENEL SEKRETERLİK

MT and SNP composite preservative as well as preparation and application thereof

The invention discloses an MT (melatonin) and SNP (single nucleotide polymorphism) compound preservative as well as preparation and application thereof, and relates to the field of compound preservative films. A nitric oxide donor sodium nitroprusside (SNP); tween-80 (Tween-80) is added into auxiliary components to serve as an emulsifying agent, MT and SNP are dissolved in a proper amount of water and evenly stirred, then Tween-80 is added, and the MT and SNP compound preservative is prepared, according to the MT and SNP compound preservative and preparation and application thereof, MT and SNP are natural or quasi-natural components, compared with chemical preservatives, the MT and SNP have smaller potential harm to the environment and the human body, MT and SNP are used in a compound mode, and therefore the MT and SNP compound preservative has the beneficial effects that the MT and the SNP are more environmentally friendly and more environmentally friendly. MT and SNP cooperate with each other to improve the fresh-keeping effect, the antioxidant effect of MT can reduce oxidative damage in the fruits, SNP promotes endogenous NO generation, can regulate signal transduction in the fruits and further inhibits respiration and ethylene synthesis of the fruits, maturing and aging of the fruits are delayed from different angles through cooperation of MT and SNP, and the fresh-keeping effect of the fruits is improved. Meanwhile, the MT and the NO can cooperatively regulate and control signal transduction in the plant body, and the action time of the NO in the fruit body is prolonged.
Owner:LINGNAN NORMAL UNIV

Nitric oxide donor-containing compounds

The present invention relates to the technical field of pharmaceuticals, and in particular to a class of nitric oxide (NO) donor-containing compounds or pharmaceutically acceptable salts, a preparation method therefor, a pharmaceutical composition, and a use thereof in the treatment or prevention of an ocular hypertension-related ophthalmic disease and an optic nerve injury-related disease.
Owner:SUZHOU RAYMON PHARMA CO LTD

A multi-point in-situ detection device for nitrite and nitric oxide

The invention relates to the technical field of air detection, and in particular to a multi-point in-situ detection device for nitrous acid and nitric oxide, comprising a shunt collection pipeline, a multi-section extractor, an air suction pump, a cleaning circulation pipeline and a circulation cleaning device; the shunt collection pipeline is installed in a collection area, and the shunt collection pipeline is provided with a plurality of collection ends distributed in different collection areas; the multi-section extractor is installed at the output end of the shunt collection pipeline, the interior of the multi-section extractor is connected with a nitrous acid detector and a nitric oxide detector, the air suction pump is connected with the shunt collection pipeline, and the air suction pump is used to suck the gas inside the shunt collection pipeline; the cleaning circulation pipeline is installed above the shunt collection pipeline, and the cleaning circulation pipeline is provided with a plurality of liquid outlet ends, and the liquid outlet end of the cleaning circulation pipeline is connected with the shunt collection pipeline; the input end of the circulation cleaning device is connected with the shunt collection pipeline, and the output end of the circulation cleaning device is connected with the cleaning circulation pipeline. The invention can effectively improve the detection efficiency and reduce the detection cost at the same time.
Owner:NORTHEAST INST OF GEOGRAPHY & AGRIECOLOGY C A S

Process for the preparation of a nitric oxide donating prostaglandin analogue

UndeterminedLAP729ANitric acid ester preparationProstaglandin analogBoronic acid
The present invention relates to a process for preparing the hexanoic acid, 6-(nitrooxy)-, (1S,2E)-3-[(1R,2R,3S,5R)-2-[(2Z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]- 3,5-dihydroxycyclopentyl]-1-(2-phenylethyl)-2-propen-1-yl ester of formula (I). In accordance with the present invention, the compound (I) can be efficiently prepared with high purity by coupling bimatoprost in a boronate protected form with 6-(nitrooxy)hexanoyl chloride and removing the boronate protecting group. The 6-(nitrooxy)hexanoyl chloride intermediate is prepared by ring-opening reaction of 2-caprolactone and subsequent nitration of the 6-hydroxyhexanoic acid potassium salt with a mixture of HNO3 and H2SO4 in dichloromethane.
Owner:NICOX SA

Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions

The present invention relates to a liquid nitric oxide releasing solution (NORS) comprised of at least one nitric oxide releasing compound and at least one acidifying agent, wherein the NORS provides an extended release of a therapeutically effective amount of nitric oxide gas (gNO). The present invention also relates to a liquid NORS comprised of at least one nitrite compound having a concentration of no greater than about 0.5% w / v and at least one acidifying agent, wherein the NORS releases a therapeutically effective amount of gNO. The present invention also relates to a method for the treatment of a wound in a human, the method comprising administering to the human a liquid NORS comprised of at least one nitric oxide releasing compound and at least one acidifying agent, wherein the NORS provides an extended release of a therapeutically effective amount of gNO. The present invention also relates to a method for the treatment, prevention, or reduction of incidence of a disease or disorder in a human in need thereof, the method comprising administering to the human a liquid NORS comprised of at least one nitrite compound at a concentration of no greater than about 0.5% w / v and at least one acidifying agent, wherein the NORS releases a therapeutically effective amount of gNO.
Owner:SANOTIZE RES & DEV CORP

Tissue engineering heart valve stent with sulfonated nano-enzyme coating as well as preparation method and application of tissue engineering heart valve stent

The invention provides a tissue engineering heart valve stent with a sulfonated nano-enzyme coating as well as a preparation method and application of the tissue engineering heart valve stent, and belongs to the technical field of medical materials. The invention relates to a tissue engineering heart valve stent with a sulfonated nano-enzyme coating, which comprises an acellular matrix carrier, ruthenium / iridium-tannic acid nano-enzyme loaded on the acellular matrix carrier, and a sulfonated polymer coating fixed on the acellular matrix carrier and / or the surface of nano-particles through ultraviolet polymerization, the ruthenium / iridium-tannic acid nano-enzyme is formed by tannic acid TA, Ru < 3 + > and Ir < 3 + > through coordination. According to the invention, through double bionic activities of superoxide dismutase and nitric oxide synthase of ruthenium / iridium-tannic acid nano-enzyme and through the super-hydrophilicity and electrically neutral surface of the sulfonated polymer coating, collaborative regulation and control of O2-NO cascade catalysis and interface functions in a pathological microenvironment are realized; the structural and functional in-situ regeneration of the tissue engineering heart valve stent is promoted.
Owner:SICHUAN UNIV

Devices and methods for prepackaged on-demand terminal sterilization

PCT designated stage expiredWO2025075888A1Package sterilisationLavatory sanitoryMedicineDelivery system
Compositions and methods are presented in which a nitric oxide precursor, formed (preferably) from the reaction of a thiol-containing compound and a nitrosating compound, decomposes to form nitric oxide within a sealed delivery system that allows for mobile sanitation; from which the sample compartment can be separated from the nitric oxide releasing compartment with a secondary seal, then subsequently detached without altering the sterilized portion of the package.
Owner:STERILE STATE LLC

Carotid artery vasodilatation device

PCT designated stageWO2024258387A1Magnetotherapy using coils/electromagnetsArterial VasodilationArterial occlusion
The invention to the creation of a carotid artery vasodilatation device that can be used both at home or in the emergency room in addition to drug treatment in cases such as occlusion of the carotid artery in the neck area, increases nitric oxide production mediated by endothelial nitric oxide synthase in the intact endothelial layer of the carotid artery, which will be on the inner surface of the neck collar, can be applied for certain periods of time for each patient, with intermittent or continuous operation function selections by means of its adjustable power circuits, affects only the lesion area without affecting the patient's peripheral blood vessels, can be used in cases where possible use of nitrates is contraindicated, prevents the decrease in blood flow that may occur in the brain tissue secondary to constriction in the neck veins, can be kept in the application area for a long time by means of the flexible structure of the applicator neck collar (9), and comprises pulsed magnetic field (PMF).
Owner:SÜLEYMAN DEMİREL ÜNİVERSİTESİ İDARİ VE MALİ İŞLER DAİRE BAŞKANLIĞI GENEL SEKRETERLİK

Nitric oxide donor-type compound and use thereof

The present application relates to a nitric oxide donor-type compound and use thereof in the preparation of a medicament for preventing and / or treating ophthalmic diseases such as glaucoma and ocular hypertension. The compound has a structure represented by formula (I), or is a stereoisomer, tautomer, solvate, metabolite, pharmaceutically acceptable salt, or prodrug of the structure represented by formula (I).
Owner:OCUSUN OPHTHALMIC PHARM (GUANGZHOU) CO LTD

Cardiovascular stent coating capable of rapidly reconstructing endothelium and releasing nitric oxide for long time, preparation method and stent

The invention discloses a cardiovascular stent coating capable of rapidly reconstructing endothelium and releasing nitric oxide for a long time, a preparation method and a stent. The cardiovascular stent coating comprises a dopamine / hexamethylenediamine-copper coating and multiple functional substances combined with the dopamine / hexamethylenediamine-copper coating, and the multiple functional substances comprise an NO precursor, endothelial polysaccharide with the anticoagulation characteristic and growth factors capable of specifically adhering EC. The cardiovascular stent coating provided by the invention is grafted with various functional substances such as endothelial polysaccharide, growth factors capable of specifically adhering EC, NO precursors and the like, so that the defects of low NO yield, poor anticoagulation effect, incapability of quickly promoting re-endothelialization in an early stage and the like of a traditional coating are favorably improved. According to the invention, the cardiovascular stent is endowed with various functions of adhering EC, increasing anticoagulation, providing enough NO under the condition of existence or absence of an endogenous NO donor and the like, so that rapid reendothelialization is promoted, thrombosis and restenosis are prevented, and the long-term curative effect and safety of the cardiovascular stent are finally improved.
Owner:THE HONG KONG POLYTECHNIC UNIV SHENZHEN RES INST

Urinary catheter treatment

A method includes mixing a liquid carrier and a powder formulation including an S-nitrosothiol (RSNO) powder to form a nitric oxide generating solution; and within a predetermined time of mixing, introducing the nitric oxide generating solution into an inflatable and nitric oxide permeable balloon of a urinary catheter that is inserted in a patient.
Owner:THE RGT UNIV OF MICHIGAN

Activated stem cell microcapsules, methods of making and using same

The present application relates to an activated stem cell microcapsule, a preparation method and application thereof. The activated stem cell microcapsule is prepared by the following method: taking mesenchymal stem cells, culturing the mesenchymal stem cells in a culture medium containing resveratrol, collecting the supernatant, and centrifuging the supernatant by differential centrifugation to obtain the activated stem cell microcapsule; the concentration of the resveratrol in the culture medium is less than 1.5 micromoles per liter. Then the activated stem cell microcapsule is mixed with a nitric oxide donor for incubation to obtain an activated stem cell microcapsule loaded with a nitric oxide donor. The activated stem cell microcapsule and the activated stem cell microcapsule loaded with the nitric oxide donor provided by the present application have good blood vessel repair effect and can be used for preparing a drug for treating peripheral vascular lesions.
Owner:SUN YAT SEN UNIV

Nitric oxide donor based on heparin sodium as well as preparation method and application of nitric oxide donor

The invention relates to a nitric oxide donor based on heparin sodium and a preparation method and application thereof, the method comprises the following steps: (1) dissolving heparin sodium in a 2-(N-morpholino) ethanesulfonic acid buffer solution, adding an activator, and carrying out a reaction to obtain a reaction solution A; (2) adding beta-mercaptoethylamine into the reaction solution A, and continuously reacting to obtain a reaction solution B; (3) dialyzing the reaction solution B to obtain a solution C; and (4) adding tert-butyl nitrite into the solution C, and reacting to obtain the heparin sodium-based nitric oxide donor. Wherein in the step (1), the activating agent is 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide or hydrochloride of the 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. According to the prepared heparin sodium-based nitric oxide donor, the nitric oxide release time is prolonged, and the problem that the half-life period of nitric oxide is short is solved.
Owner:NANJING NORMAL UNIVERSITY